Evidence map›Paper›PMID 25186975›Full record

ArticleBiochemistry2014

Long-range stabilization of anthrax protective antigen upon binding to CMG2.

Vennela Mullangi, Sireesha Mamillapalli, David J Anderson, James G Bann, Masaru Miyagi

Abstract read
In one paragraph

Article in Biochemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Vennela MullangiCase Center for Proteomics and Bioinformatics, ‡Department of Pharmacology, and §Department of Ophthalmology and Visual Sciences, Case Western Reserve University , Cleveland, Ohio 44106, United States.
Sireesha Mamillapalli
David J Anderson
James G Bann
Masaru Miyagi
Cleveland State University · USUniversity of Kansas · USWichita State University · US

Funding

Global Characterization of Lysine Acetylation in Diabetic RetinaR21EY021595 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI KERN, TIMOTHY S, MIYAGI, MASARU · 2012 to 2013
$422k
NIGMS MARC PREDOCTORAL FELLOWSHIPF31GM010341 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NEAL, CHARLES RICHARD · 1985 to 1990
–
NEI NIH HHS R21-EY021595NIGMS NIH HHS P20GM10341
6 · The paper itself

Abstract

Protective antigen (PA) mediates entry of edema factor (EF) and lethal factor (LF) into the cytoplasmic space of the cells through the formation of a membrane-spanning pore. To do this, PA must initially bind to a host cellular receptor. Recent mass spectrometry analysis of PA using histidine hydrogen-deuterium exchange (His-HDX) has shown that binding of the von Willebrand factor A (vWA) domain of the receptor capillary morphogenesis protein-2 (CMG2) lowers the exchange rates of the imidazole C2 hydrogen of several histidines, suggesting that receptor binding decreases the structural flexibility of PA. Here, using His-HDX and fluorescence as a function of denaturant, and protease susceptibility, we show that binding of the vWA domain of CMG2 largely increases the stability of PA and the effect reaches up to 70 Å from the receptor binding interface. We also show that the pKa values and HDX rates of histidines located in separate domains change upon receptor binding. These results indicate that when one end of the protein is anchored, the structure of PA is tightened, noncovalent interactions are strengthened, and the global stability of the protein increases. These findings suggest that CMG2 may be used to stabilize PA in future anthrax vaccines.

Indexed as

Antigens, BacterialBacterial ToxinsHydrogen-Ion ConcentrationKineticsPeptide HydrolasesProtein BindingReceptors, PeptideSpectrometry, Fluorescenceanthrax toxinAntigens, BacterialANTXR2 protein, humanBacterial ToxinsPeptide HydrolasesReceptors, Peptide

Identifiers

PMID25186975
PMCPMC4179592
OpenAlexW2316637298

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.